Twist Bioscience Corp at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 06:05PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

I'm Luke Sergott, I cover life sciences tools and diagnostics here at Barclays. It's my pleasure to have Emily Leproust, the CEO of Twist; and Jim Thorburn, the CFO. So we're already kind of 30 seconds over. So when I say we just started jumping into that stock -- the shock clock. So I don't know.

Questions and Answers:

Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

I look at where the business is now versus where it was in 2018 and I look at where the stock is now versus where it was in 2018, and there's a massive disconnect here. Can you walk through how you see -- I mean the business is from -- it's 6x the size it was back then? Talk about the evolution here and really the forward trajectory as you see it from the business as it is today, versus where it's trading.

Emily Marine Leproust - Twist Bioscience Corporation - Co-Founder, Chairman & CEO

Yes. I mean in 2018, at the time of the IPO, the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot